About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT01541540

e-Counseling Promotes Blood Pressure Reduction and Therapeutic Lifestyle Change in Hypertension

This proposed clinical trial, REACH, will enroll 538 persons with hypertension. All subjects will continue with their prescribed medications. Our main objective is to assess whether preventive e-couns...

Lead sponsor: University Health Network, Toronto•4 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

University Health Network, Toronto

Age

35 - 74 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Age: 35-74 years
•Diagnosis of hypertension: Medication or physician confirmation
•Baseline BP in lab: \>=140/90 (if no meds); \>=130/85 (if on meds)
•If medications, prescription unchanged \>=2 months Comprehension of English (oral and written)

Exclusion Criteria

•diagnosis of clinically significant arrhythmia, sleep apnea, kidney disease, major psychiatric illness (eg. psychosis), alcohol or drug dependence in the previous year; institutional residence, or an inability to comprehend English

Related studies

Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women

NCT06647511 · Gestational Hypertension

RECRUITINGPhase 1/2

Feasibility of Semaglutide in Advanced Lung Disease

NCT05746039 · Obesity, Interstitial Lung Disease, and more

Exploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Placement

NCT07439939 · Liver Cirrhosis, Portal Hypertension

RECRUITINGPhase 3

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

NCT07218029 · Pulmonary Arterial Hypertension

Health Warnings and Counseling for Smoking Cessation

NCT07098065 · Tobacco Cessation, Health Warning Label, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 7, 2016Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment264

Start dateFeb 2012

Last updatedOct 7, 2016

Condition

Locations shown

Vancouver Coastal Health

Vancouver, British Columbia

London Health Science Center

London, Ontario

Grey Bruce Health Unit

Owen Sound, Ontario

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 7, 2016Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions